Sarepta Therapeutics (SRPT) Revenue Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.19% |
| Dec 31, 2025 | 81.49% |
| Sep 30, 2025 | 77.77% |
| Jun 30, 2025 | 88.00% |
| Mar 31, 2025 | 58.75% |
| Dec 31, 2024 | 45.75% |
| Sep 30, 2024 | 36.37% |
| Jun 30, 2024 | 30.84% |
| Mar 31, 2024 | 36.58% |
| Dec 31, 2023 | 40.58% |
| Sep 30, 2023 | 33.42% |
| Jun 30, 2023 | -21.26% |
| Mar 31, 2023 | 31.44% |
| Dec 31, 2022 | 24.19% |
| Sep 30, 2022 | 35.22% |
| Jun 30, 2022 | 43.25% |
| Mar 31, 2022 | 6.13% |
| Dec 31, 2019 | 417.40% |
| Sep 30, 2019 | 147.85% |
| Jun 30, 2019 | 105.50% |
| Mar 31, 2019 | 70.22% |
| Dec 31, 2018 | 100.18% |
| Sep 30, 2018 | 79.88% |
| Jun 30, 2018 | 90.24% |
| Mar 31, 2018 | 70.57% |
| Dec 31, 2017 | 50.84% |
| Sep 30, 2017 | 43.42% |
| Jun 30, 2017 | 25.59% |
| Mar 31, 2017 | 7.83% |